ECDC public consultation on the use of neuraminidase inhibitors

References

1. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD008965. . Available from: onlinelibrary.wiley.com/cochranelibrary/search https://doi.org/10.1002/14651858.CD008965.pub4http  PMID: 24718923 
2. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-37. . Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62449-1/abstract https://doi.org/10.1016/S0140-6736(14)62449-1  PMID: 25640810 
3. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395-404. . Available from: http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(14)70041-4/abstract https://doi.org/10.1016/S2213-2600(14)70041-4  PMID: 24815805